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Lipid changes within the epidermis of living
skin equivalents observed across a time-course
by MALDI-MS imaging and profiling
Christopher A. Mitchell1, Heather Long2, Michael Donaldson2, Simona Francese1 and Malcolm R Clench1*
Abstract
Background: Mass spectrometry imaging (MSI) is a powerful tool for the study of intact tissue sections. Here, its
application to the study of the distribution of lipids in sections of reconstructed living skin equivalents during their
development and maturation is described.
Methods: Living skin equivalent (LSE) samples were obtained at 14 days development, re-suspended in maintenance
medium and incubated for 24 h after delivery. The medium was then changed, the LSE re-incubated and
samples taken at 4, 6 and 24 h time points. Mass spectra and mass spectral images were recorded from 12 μm
sections of the LSE taken at each time point for comparison using matrix assisted laser desorption ionisation
mass spectrometry.
Results: A large number of lipid species were identified in the LSE via accurate mass-measurement MS and
MSMS experiments carried out directly on the tissue sections. MS images acquired at a spatial resolution of
50 μm × 50 μm showed the distribution of identified lipids within the developing LSE and changes in their
distribution with time. In particular development of an epidermal layer was observable as a compaction of the
distribution of phosphatidylcholine species.
Conclusions: MSI can be used to study changes in lipid composition in LSE. Determination of the changes in
lipid distribution during the maturation of the LSE will assist in the identification of treatment responses in future
investigations.
Keywords: MALDI-MSI, MALDI, Mass spectrometry imaging, MSI, Lipids, Living skin equivalents
Background
Living skin equivalent (LSE) models are an important re-
source for skin research and are commonly employed as
an alternative to the use of ex-vivo mammalian tissue or
in-vivo experiments in the pharmaceutical and cosmetics
industries. A wide variety of the skin models are com-
mercially available and can be manufactured in-house
with features tailored to a particular need [1].
As a major component of skin, lipids play important
roles in cellular functions and are agents within cell sig-
nalling cascades. Ceramide metabolism for example is
known to be highly compartmentalized, since, because
ceramides are highly hydrophobic; they tend to reside in
the specific membranes where they are generated, unless
transported elsewhere [2, 3]. Psoriasis and atopic derma-
titis skin lesions on inspection usually present a deficiency
in ceramide and water content [4]. The progression of
proliferation and differentiated states in skin can be corre-
lated with the content of ceramides and glycophospholi-
pids in a targeted manner, supporting both biomarker
discovery within skin pathology and pharmacodynamic
investigations.
Mass spectrometry imaging (MSI) is a relatively new
technique for the analysis of compounds in the skin, it
offers great promise since it is able to detect and plot
the distribution of multiple compounds simultaneously
in a label-free manner [5]. In addition, by employing
tandem MS analysis, the detailed structure of metabolite
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molecules, such as lipids, can be identified directly on
the tissue sections; thus, it can be confirmed that the ob-
served mass signals are derived from the molecules of
interest. MSI has been previously used to analyse human
skin biopsies taken from patients with eczema. In this
case a role for glycosphingolipids in disease pathogenesis
was observed [6].
We have previously reported the use of MALDI-MSI
to study the disposition of a topical compound absorbed
in porcine skin [7]. Since then however there have been
few publications, dealing with skin and MSI analysis.
The correlation of skin blanching and percutaneous
absorption of a glucocorticoid receptor agonist was
reported by Marshall et al., [8]. Prideaux et al., [9] re-
ported the examination of xenobiotic compounds in skin
tissue sections by indirect MALDI-MSI and more re-
cently Hart et al., [10] analysed ex-vivo human skin via
MSI. Enthaler et al., [11] demonstrated that small en-
dogenous species such as cholesterol sulphate can be
mapped by MSI in the stratum corneum. Recently MSI
was used for the examination of imipramine absorption
in a LSE [12]. Although the metabolism of the drug was
examined i.e. drug pharmacokinetics, changes to the skin
in response to the pharmaceutical compound i.e. phar-
macodynamic responses were not investigated.
Here we report a study of the distribution of lipids
within LSE and an examination of cell differentiation in
the LSE across a time-course. Multivariate statistical ana-
lysis has been employed to discriminate inter-spectral ion
changes of significance so that the distribution of pro-
jected ions could be imaged. The generated datasets will
provide a reference point to examine in-vitro disease
equivalent models and lipid responses to treatment in fu-
ture investigations.
Results
MALDI-MS and MALDI-MS/MS analysis of LSE sections
A representative mass spectrum obtained from the un-
treated LSE 24 h incubation sample group is shown in
Fig. 1. The spectrum shows the large number of lipid spe-
cies present within the sample. Additional file 1: Table S1
shows the results of the database search of the accurate
masses (5 ppm) of detected peaks. The lipid groups
identified and reported in the table include free-fatty acids,
glycerophosphonoethanolamines, glycerophosphocholine,
sphingolipids and triacylglycerols. Phosphatydlcholine (PC),
sphingomyelin (SM) and lyso phosphatydlcholine (LPC)
species appear to be most dominant in the average spectra.
PC lipids were particularly populated between the m/z 670
and 900 range with intensity counts approximately 4 times
greater than the other low abundant signals at the lower
mass ranges. Many of the detected compounds including
PC 34:2 (m/z 780.5 M+Na+), PC 36:2 (m/z 786.6 M+H),
PC 36:1 or PE 39:1 (m/z 810.5 M+Na+) were previously
identified in ex-vivo human skin also [10]. The dominance
of phospholipids in the spectra is probably due to their bio-
logical abundance in tissue; the fixed positive charge from
the choline head-group allows PC species to have strong
ionisation efficiencies.
A common feature in the data, ion m/z 703.5 was tenta-
tively assigned as sphingomyelin (SM) 34:1 from prior ex-
perimentation [10]. To further characterise this feature
we observed the ion mobility drift time plot for the
MALDI-IMS-MS profiles of control LSE tissue and a
SM (d18:1/16:0) standard both in the presence of lithium
salts and then without. A common drift-time value of 101
can be observed in Additional file 1: Figure S1a for the m/z
703.57 [M+H]+ ion and the m/z 709.56 [M+ Li]+ ions re-
spectively. Additional file 1: Figure S1b shows IMS-MS/MS
data obtained from the peak at m/z 709.57. The MSMS
spectrum for the selected precursor ion (m/z 709.57) gave
product ions that were expected for the SM (d18:1/16:0)
compound and also some that were assigned as arising
from structural isomers e.g. m/z 236.2; which is known to
represent the d16:1 long chain base of a ceramide structure
rather than the d18:1 chain. Additional file 1: Table S1 indi-
cates which of the tentatively identified lipids were verified
via MSMS alone by comparison of MSMS spectra to au-
thentic lipid standards and where ion mobility drift times
were employed.
By manual examination of the full mass spectral data set
it was possible to find instances where ceramides were not
dominated by phosphocholine in the spectra. This ap-
peared to correspond to the uppermost edge of the skin.
There were common features in the spectra which ap-
peared to be structural motifs of the ceramide lipid family,
particularly m/z 264.2668 and 256.2599 (d18:1 side chains).
A number of possible dehydrated ceramide features de-
tected with the loss of H2O [M+H-H2O] via high accurate
mass measurement; i.e. m/z 534.5 cer (d15:1/20:0) and m/z
520.2 ceramide 16 (N-paltimitoylsphingosine), could be
putatively identified. Some sphingolipid signals which are
incorporated into higher structures were interrogated fur-
ther in the imaging experiment.
Fatty acyls particularly monounsaturated species in the
smaller mass range had a much lower signal to noise ratio.
This low abundant phenomenon appears to be a common
finding in skin models and has been previously reported
by Thakoersing et al., [13, 14]. Tentative identifications in-
clude oleic acid ([M +H]+, m/z 283.2620), linoleamide
([M +H]+, m/z 280.2655), acetic acid ([M +K]+, m/z
98.9828) and eicosenic acid ([M +H]+, m/z 311.2875) re-
spectively. Isobaric hexadecadienal variant species at m/z
237.2175 were difficult to distinguish from each other
through ion-mobility alone. Matrix clusters were abun-
dant in the fatty acyl mass range.
As anticipated phosphatidylinositols (PI) and phospha-
tidylserines (PS) and cholesterol species were of low
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abundance in the spectrum as they are better ionised in
the negative mode.
Multivariate statistical analysis of spectra across time-
course (4, 6 and 24 h)
Principle component analysis (PCA) scores and loadings
plots were performed to identify changes that occurred in
the LSE samples during the time course study. Figure 2
shows the PCA plots obtained from the analysis of the
spectra taken from the epidermis alone: Fig. 2a, c shows
the scores plot giving the extent of groupings and variabil-
ity between the skin spectra at different time points.
Figure 2b and d shows the loadings plot comprising of the
spatial distribution of m/z spectral species in correspond-
ence to the scores plot positions. Figure 2a and b show
the corresponding scores and loadings plots for observable
changes in epidermal regions; Fig. 2c, d for the dermis.
The epidermis PCA scores plot (Fig. 2a) show an overall
trend which is that; the 24 h group is more separated in
the PCA space than the 4 and 6 h spectra groups. For the
scores plots for in the dermal region however (Fig. 2c), the
spectra seemed to associate more with each other as the
time-course progressed; the 4 h group being the most dis-
tinct. In the loadings plot obtained from the epidermis
data (Fig. 2b) it can be seen that m/z 759, 757 and 732 are
major contributors to the observed variance. Examination
of the dermis PCA loadings plot (Fig. 2d), suggests that
m/z 760, 758, 732 and 734 appeared to distinguish the 4 h
group within the lower right quadrants of the loadings
plot.
MALDI-MS Imaging analysis of LSE sections
MALDI-MSI-IMS images were acquired from LSE tissue
derived from 3 biological samples incubated for 4, 6 and
24 h per experiment. The spatial resolution was set to
50 μm × 50 μm. Images were processed using Waters
HDI software (Waters Corporation); which incorporates
the added measurements of ion mobility.
In the imaging experiments it was possible to gain fur-
ther information using spotted lipid standards in the image
path but just off the tissue. Figure 3a shows that some of
the ions detected are fragment ions of larger species e.g.
SM (d18:1/16:0). Here, m/z 520.5024 detected in tissue at a
drift-time value of 51.98 is also observed as a fragment ion
of the SM (d18:1/16:0) lipid standard. It can be assigned to
loss of cyclophosphane [H (HO) P (O) (OCH2CH2O)] m/z
183, from the protonated SM species, forming N-
paltimitoylsphingosphine. Similarly the m/z 644.4309 ion
corresponds to a loss of trimethylamine N (CH3) m/z 59.
The fragment ion m/z 256.2599 corresponds to the d18
Fig. 1 Positive ion MALDI Mass spectrum of a LSE (24 h incubation) across the full thickness of the tissue, using α-CHCA/ANI as a matrix
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Fig. 2 (See legend on next page.)
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side chain within the sphingolipid structure. When the im-
ages of the fragment species (e.g. m/z 520.5024 and
644.4309) were compared with the protonated and sodium
adduct ion images (m/z 703.5669 and 725.5487) a similar
distribution of signal was observed between images; the
main difference being intensities as expected.
In addition, other structural ion markers could be
visualised in multiple combinations of lipid standards
and in tissue (Fig. 3b). The lipid standards in addition to
SM d18:1/16:0 includedglycosphingosine, sphingosylpho-
sphorylcholine (SPC), ceramide 6 (hexanoyl-D-erythro-D-
sphingosine) and C18:1 ceramide (N-oleoyl-D-sphingosine).
When mapping ion m/z 264.2653 a distribution of signal
was visualised in tissue and abundantly within the ceramide
6, SM (d18:1/16:0) and C18:1 ceramide lipid spot standards,
with moderate signal found in the glycosylsphingosine spot
standard and trace signals in the SPC lipid spot. When
mapping ions within the ceramide mass range, signals were
visualised in the tissue and in particular spot standards in
some instances, for the various sphingoid base lipid struc-
tures as shown in Additional file 1: Figure S2. Thus the spot
standards could be used to support putative identifications
using the side chain markers. Identification of some choline
rich species was also supported in a similar way, particularly
with the use of the PC (16:0/18:1(9Z)) and SM (d18:1/16:0)
lipid spot standards.
Figure 4 shows MALDI-MS images of identified lipid
compounds in the tissue. Trigylcerol (TG) 54:3 (m/z
907.7566 [M+Na]+) is a marker of the stratum corneum;
its distribution can be observed at the outer most regions
of the skin sections, as reported also by Hart et al., [10].
The ceramide species when visualised appeared less in-
tense generally in comparison to the PC lipid ion maps in
the tissue. Some broad differences could be observed be-
tween the tissue sections (4, 6, 24 h) for most of the im-
ages. The distribution of the ceramide and PC ions in the
24 h sample appeared to be located primarily towards the
top outer region of the tissue section, whereas in the 4
and 6 h skin sections, the signal is observed throughout
the sections.
The PCA plots show ions which are major contribu-
tors to variances in the epidermis (Fig. 2a, c). Figure 5
shows MALDI-MS images for the distribution of the ion
m/z 759.5592 which was projected to vary significantly
between the dermis and epidermis from the PCA load-
ings plot. From these images some changes can be visua-
lised: the distribution of the ionm/z 759.5592 changes
with time; in the 24 h sample it is located primarily at
the edge of the epidermis whereas in the 4 and 6 h tissue
sections the signal is observed throughout the sections.
This is also the case for the ions m/z 757.5411 and m/z
732.5531. These species have been tentatively identified via
accurate mass measurement (Additional file 1: Table S1) to
an error of 5 ppm. Repeat studies carried out on a different
instrument gave the same findings; a distinct epidermal
band can be seen when mapping select ions, particu-
larly for the 24 h sample section. This is particularly
shown for the ions m/z 759.5 and 703.5 ions. When
directly comparing the Oil Red O stained sections
across the time-course, noticeably some basal and
granular epidermal layer changes can be seen in the
later time-point. The epidermal region appears more
compressed and dense in the 24 h sample, whereas the
4 h sample is thicker in appearance and less compact.
Some lipid droplets can be found in the 24 h sample
epidermis. Intriguingly the 24 h stratum corneum ap-
pears darker indicative of being a richer neutral lipid
layer.In all cases a stratified epidermis could be visua-
lised as a red band across the outer region of the skin.
This stratified feature can also be shown as a dark pur-
ple edge in the haematoxylin and eosin stained sections
across the time-course (Fig. 6).
In order to confirm the observed changes in the distri-
butions of significant lipids in the 24 h samples, 3 bio-
logical replicates of the 24 h time point were imaged
simultaneously (Fig. 3). The resulting images show that in
each instance across the three sections of the 24 h LSE
group, the selectivity of signal for the epidermal edge was
a common feature for a broad number of choline rich lipid
species. Spots of lipid standards (placed slightly off of the
tissue) were included in the imaging experiment and the
fact that signals from them were also visible as signals in
the tissue added further confirmation to our putative lipid
identifications. Species examined in this way were; SM
(d18:1/16:0); and PC (16:0/18:1(9Z)).
Discussion
Generally when employing MSI a number of specifica-
tions and tolerances need to be considered. A com-
promise is usually drawn between peak resolving power
with mass accuracy; and the potential for focusing the
laser spot diameter with high image resolution, which
leads to a loss in sensitivity. Here the use of high mass
accuracy and ion mobility separation capabilities en-
abled separation of isobaric species and precise profil-
ing of the epidermis.
(See figure on previous page.)
Fig. 2 Principal component analysis of MALDI-MS spectra acquired from LSE. Score plots were generated showing groupings and variability
between the 4, 6 and 24 h group spectra from the a) epidermis or c) dermis regions of the skin. The loading plots show a distribution of m/z
spectra ion species which are contributors of grouping and variability in the b) epidermis or d) dermis between the time-course groups; the
quadrant space in corresponding between the plots
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As shown in Additional file 1: Table S1, m/z 759.5592
was tentatively identified as an in-source fragment ion of
the lipid PC 38:0 and assigned as [M+H – 59 Da]+. The
ion m/z 757.5411 was identified as either PC 38:1 or PE
41:1[M +H – 59 Da]+. These ions were indicated as major
contributors of variance in the epidermis. It should be
Fig. 3 a MALDI-MSI-IMS image mapping the in-source fragment m/z ion species for SM (d18:1/16:0) in tissue and within a SM (d18:1/16:0) lipid
standard. Particularly m/z 520.5024 is likely to be the N-paltimitoylsphingosine unit of the structure following neutral loss of cyclophosphane [H
(HO)P (O) (OCH2CH2O)] m/z 183. The ion m/z 644.4309 correspond to a loss of trimethylamineN (Ch3) m/z 59 from the M + H adduct. Ion map
for m/z 256.2599 represents the d18 side chain of the SM lipid structure. The approximate fragment conformations are depicted in the structural
diagram. b. MALDI-MSI-IMS of commonly occurring fragment ions found within tissue and lipid standards representative of fatty acyl side chains
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noted however that there is still an inherent lack of side-
chain specificity when choline-based glycerophospholipids
are analyzed in positive ionization mode, as the loss
observed is often simply the 184 choline fragment. This
means that it is only possible to state that the molecule
contains a fatty acid sidechain pool containing a total
Fig. 4 MALDI-IMS-MSI images mapping the protonated and sodiated ions for ceramides and PC species across skin equivalent tissue sections
representing the three time-stages within the time-course study (4, 6 or 24 h incubation period [from left to right]) and across lipid standards.
Images are at a spatial resolution of 50 μm × 50 μm and are normalised against the total ion count
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carbon and unsaturation state e.g. 38:0 as stated here.
There are a number of possible arrangements for the fatty
acids at SN2 i.e. 20:0/18:0, 22:0/16:0, 24:0/14:0, etc.
Ceramides in the LSE were visualised mostly as their
sodiated adduct [M+Na]+. It was possible to aid structural
identification of the ceramides in the LSE by incorpor-
ating sphingolipid spot standards in the MSI experi-
ment. The tissue ion signals which corresponded with
ceramide 6 and glycosylsphingosine spotted standards
(as shown in Additional file 1: Figure S2) were important
Fig. 5 MALDI-IMS-MS images mapping the ions m/z 759.56, 757.54, 732.54 and 703.56 in skin equivalent tissue, at the different stages of a time
course (4, 6 and 24 h respectively). a - (c) m/z 732.54 at 4,6, and 24 h, (d)-(f) m/z 757.54 (g)-(i) m/z 759.56 at 4,6 and 24 h and (j)-(l) m/z 703.56 at
4,6, and 24 h . These signals were identified from the PCA data as being significant contributors of change in the spectra between the epidermis
and dermis. Images are at a spatial resolution of 50 μm × 50 μm and are normalised against the total ion count. Optical images of Oil Red O
stained sections of the tissue at the different stages of a time course (4, 6 and 24 h respectively) are also shown (m)-(o)
Fig. 6 Haematoxylin & eosin stained skin section against a MALDI-MS map of skin sections focusing on the 24 h time-point, showing the potential of
the 50 μm × 50 μm resolution to discern epidermal ultrastructural region
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for determining the identifications of sphingoid base cera-
mides. Such methods for the identification of lipids
assisted with spotted standards within the imaging path
will be developed further as an alternative to MSMS im-
aging which only observes products for one ion per image.
This could enhance the workflow of untargeted lipidomic
investigations where the lipid identification process is
often labour intensive; and in some instances biased if the
risk of ion carryover between tissue and compound stan-
dards is not supervised. Ceramide species vary widely in
their carbon chain lengths, extent of unsaturation and in
the extent and positioning of hydroxylation in both the
fatty acyl and sphingoid moieties [15, 16]. The hope is
that, for example, the identification of hydroxyl and non-
hydroxylated ceramides can be aided by the identification
of characteristic in-source fragment ion patterns using
synthetic sphingolipid standards and tissue (characterised
by intensity, mass accuracy and drift time) within an im-
aging experiment. This approach could of course be ex-
tended to other lipid classes as well. Spotted standards
enabled a combination of mass accuracy and ion mobility
drift time values to be matched instantly and independ-
ently across the two lipid sources.
Examination of the distribution of the identified phos-
pholipids in the LSE (Figs. 4 and 6), indicates that they are
not present in the stratum corneum but at an epidermal
junction likely to be the stratum granulosum. Figure 6
shows enlarged MALDI-MS and Haematoxylin and Eosin
images of the 24 h sections.
It is reasonable to assume that a human LSE consist-
ing of human keratinocytes, would closely model the
lipid activities that likely occur in-vivo in native skin. It
has been shown previously that a marker of the stratum
corneum, cholesterol sulphate, could be mapped in skin
via negative ion MALDI-MSI [11]. Such lipid features
are assumed to be constantly present in the epidermis
via highly regulated processes, since it has a role in epi-
dermal desquamation [17, 18]. Here the disposition of
TG 54:3 has been shown to be a consistent feature in
the stratum corneum in the skin model and this agrees
with our own previously published work on the study of
ex-vivo human tissue by positive ion MALDI-MSI [10].
A central role for TG in epidermal processes may exist.
For lipids which are more ubiquitously found across
most regions of the tissue, their discrete roles are yet to
be determined. Further comparison of Fig. 1 with the
previously published data on lipids in the epidermis of
ex-vivo human skin [10] shows marked consistency in
the species observed (but not the signals. In the previous
study abundant signals for ions of the form [M +H]+
were observed e.g. SM 34:1 [M +H]+m/z 703.6 and PC
34:1 [M +H]+m/z 760.6, here whilst the same lipid spe-
cies are observed they are seen as there sodium adducts
i.e. SM 34:1 as [M +Na]+ at m/z 725.53 and PC 34:1 as
[M +Na]+ at m/z 782.54. This difference can be accounted
for by the extra washing steps to remove salts used in our
previous work| [10].
A consistent observation in the MALDI-MS images is
that a depletion of phospholipids and glycerosphingoli-
pids occurs across the time-course study. The choline
rich lipid features m/z 759.5, 757.5, 732.5 and 703.5 are
visualised across most of the tissue dermis and epider-
mis in the early time-points; however at the 24 h time-
point, the prominent ion features are localised within
the compressed epidermal region, with less signal in the
dermis. Phospholipids are constituents of membrane bi-
layers in cellular organelles of viable cell layers and so
the presence of PC species is expected throughout the
tissue section. In addition to this, the PC content has
been suggested to gradually decrease during keratinocyte
differentiation [19]. This is observed as the PC species
are not detected in the stratum corneum, although rich
in the epidermis. A proportion of the PC content in the
epidermis is likely to derive from the subcellular organ-
elles. Phospholipids are also precursor lipids contained
within the lamellar bodies, along with glycosphingolipids
and free fatty acids. It is known that at the stratum gran-
ulosum epidermal interface, the subcellular organelles
release their contents into the extracellular spaces [2].
At this 24 h point it could be questioned whether the
changes observed in lipid distribution are to do with cell
turnover or cell signalling effects; however the histology
data shows a significant compression of the epidermis.
This is indicative of cell migration towards the outer sur-
face. A reduction of the epidermis surface area could cor-
respond to cell transformation from corneocytes into
flattened keratinocyte cells. The MALDI-MS images of
the choline head group m/z 184 showed the presence of
intact tissue across the full thickness of each tissue section,
particularly for the 24 h section (data not shown). In all
skin models the cells flatten out as the apical surface of
the tissue is approached. However, this transition from cu-
bical basal cells to flat granular cells has been shown in
the past to occur abruptly in SkinEthic and Episkin cul-
tures [20]; perhaps a factor worth eliminating in the study
of cell differentiation in skin equivalent models.
Conclusions
This work reports identification of lipid changes in LSE
which were observed over a time-course experiment by
MALDI-MSI. The changes identified in the data are associ-
ated with cell differentiation in the dermis and epidermis.
In future experiments we will study the effects of topical
compounds designed for the treatment of psoriasis and ec-
zema on lipids in LSE. The data reported here will help to
differentiate between pharmacodynamic effects arising
from the applied compounds and the normal processes of
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Chemicals used for MALDI matrices and instrument cali-
bration - alpha cyano-4-hydroxycinnamic acid (α-CHCA),
aniline, methanol (MeOH), trifluoroacetic acid (TFA), lith-
ium chloride (LiCl) and phosphorus red were purchased
from Sigma-Aldrich (Gillingham, UK). Carboxymethylcel-
lulose (CMC) used for embedding samples was purchased
from Sigma-Aldrich (Gillingham, UK). For tissue staining
protocols haematoxylin, eosin, oil red o, xylene, ethanol
(EtOH), triethyl phosphate (TEP) and glycerol gelatine
mountant medium were obtained from Sigma-Aldrich
(Gillingham, UK). Dulbecco's phosphate-buffered saline
and Dulbecco's modification of Eagle's medium, used
for tissue washing, were purchased from Invitrogen
(Paisley, UK). Lipid standards including sphingomyelin
(SM) (d18:1/16:0), glycosphingosine, sphingosylphosphor-
ylcholine (SPC) and ceramide 6 (hexanoyl-D-erythro-D-
sphingosine) were purchased from InstruChemie (Delfzyl,
Netherlands). C18:1 ceramide (N-oleoyl-D-sphingosine)
and PC (16:0/18:1(9Z)) (2-oleoyl-1-palmitoyl-sn-glycero-
3-phosphocholine) was purchased from Sigma-Aldrich
(Gillingham, UK).
Ethical Statement
Ethical review, under the Human Tissue Act (HTA) was
not required for this work as the types of human tissue
that are covered by the HTA are referred to as ‘relevant
material’. Relevant material as defined by the HTA in-
cludes materials that have come from a human body,
whether living or dead, including body parts, organs and
human cells. Cell lines, such as those used to construct
the living skin equivalents used here are not relevant
material (although primary cell cultures are). “Storage of
cell lines for research does not require a licence nor does
research using cell lines require ethical review”.
Living skin equivalent samples
Labskin™ living skin equivalent (LSE) samples were pro-
vided by Innoven (York UK) after 14 days of develop-
ment. LSE were delivered as 4.5 cm2 ‘surface area
inserts’ within transport culture medium. On delivery
LSE were partially suspended in LabSkin™ maintenance
medium so that the cells were nourished and suse-
quently incubated overnight for 24 h within 5 % CO2,
37 °C to normalise their metabolism.
Skin equivalent time-course experiment protocol
After 24 h incubation the medium was changed for fresh
LabSkin™ maintenance medium and LSE samples were
incubated for further periods of 4, 6 or 24 h. At the
chosen time points samples were removed from the
medium washed with Dulbecco’s phosphate buffer solu-
tion and left to dry for 5 min at ambient conditions in the
holding wells. To quench biological metabolism, the sam-
ples were then control frozen to −80 °C using a Grant
Asymptote EF600 control freezer and stored at −80 °C
until ready for analysis.
Tissue and lipid standard preparation
For analysis by mass spectrometry imaging and conven-
tional histology 12 μm tissue sections were cut using a
cryostat (Leica 2000 UV, Leica Microsystems, Milton
Keynes, UK) and were thaw mounted onto conventional
glass slides. Sections from each time group were thaw
mounted onto the same glass slide, so that they could be
directly compared. The mounted sections were carefully
washed for 20 s with deionised water to remove any ex-
cess salts and other impurities from the skin. Excess
water was tapped off and the mounted tissue sections
were left to dry briefly in ambient conditions.
Lipid standards each made up at 500 ng/μl (70 %
MeOH) including sphingomyelin (d18:1/16:0), ceramide 6
(hexanoyl-D-erythro-D-sphingosine) and PC (16:0/18:1(9Z))
(2-oleoyl-1-palmitoyl-sn-glycero-3-phosphocholine) were
spotted (1 μl) at a remote distance to the tissue sections for
imaging and profiling correspondence to that which may
be present endogenously in the sample. These spots were
left to dry in ambient conditions.
Matrix deposition
For imaging, a matrix solution of 5 mg/ml α-CHCA dis-
solved in a 70 % MeOH and 0.2 % TFA solution was
made up with an equimolar amount of aniline added to
the final volume. The matrix was then deposited onto
the tissue section surface and over lipid spot standards
using a SunCollect™ automated sprayer (KR Analytical,
Sandbach, UK).
For MS/MSMS experiments, 100nM of LiCl was dis-
solved in 70 % MeOH, 0.2 % TFA, with αCHCA being
added to the solution to give a concentration of 10 mg/ml.
This was then spotted at particular skin regions across the
section (1 μl) for profiling; other similar tissue regions
were spotted with the non-lithiated matrix for comparison
purposes.
Direct On-tissue and lipid standard MALDI-MS and MS/MS
profiling
All analysis were carried out in the positive mode over a
mass range of; 50–1000 Da. Ions acquired at 200 laser
shots were accumulated at a single position on all
MALDI-MS instruments. For MS and MSMS profiling,
we adjusted the collision energy (approximately between
2 eV-60 eV) and laser energy (approximately between
185–200 arbitrary units) to produce a decent signal to
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noise ratio for parent ions and product ions respectively
on all MALDI instruments. MS acquisition times varied
depending on the focus/purpose of the acquisition. All
spectra were post-spectrally calibrated by aligning the
measured α-CHCA [M +H] mass with the expected
mass (m/z 190.050 [M +H]).
MALDI-MS and MSMS spectra were acquired directly
from the surface of the in-situ skin section samples and
lipid spot standards. Analysis was performed using a
Waters MALDI HDMS Synapt™ G2 mass spectrometer
(Waters Corporation, Manchester, UK) equipped with
an Nd: yttrium aluminium garnet (Nd:YAG) laser oper-
ated at 1 KHz. The Instrument was calibrated prior to
analyses using phosphorus red. The laser spot diameter
on the Synapt™ G2 was fixed to 100 μm respectively, suf-
ficient to the width of the epidermis. The peak resolving
power was set to Resolution Mode (20,000 FWHM).
Using the Synapt™ G2 MS profiles occurred along the
epidermis only, or was performed across the full thick-
ness of the tissue. The MS acquisition data was cen-
troided and subjected to post-spectral calibration within
the Mass Lynx (Waters Corporation, UK) software tool
by performing lock mass of the α-CHCA matrix ion
products.
Particularly for the data acquired from the Synapt™ G2,
lipids were tentatively identified by accurate mass mea-
surements against values in the Lipidmaps/mMass data-
bases; (mMass lists the masses of possible cationic species
for specified lipid compounds). The chemical structure of
lipids (as listed on http://www.lipidmaps.org/) that had
been assigned with the greatest accuracy (mass tolerance
of 5 ppm) were then compared with product ions ob-
served in individual MSMS spectra to confirm identity.
MSMS spectra were processed in mMass.
Multivariate Statistical Analysis and Data processing
Five spectra from the epidermis and/or dermal region
respectively for each LSE sample section representing
the three time-points (4, 6 or 24 h) were incorporated
into a dataset for statistical comparisons (in spectral
changes across the time-course per skin layer region).
MALDI-MS profiles were attained from the biological
specimens at fresh positions. Following post spectral
processing (automatic peak detection, post spectral cali-
bration), data lists were exported from Mass Lynx
(Waters Corporation, UK) as text files and imported into
Marker View software 1.2 (Applied Biosystems/MDS
Sciex, Concorde, Ontario, Canada), where it could be for-
matted into a table. An exclusion list to remove known α-
CHCA peaks was applied to the datasets, to remove the
influences of the matrix signals when observing relation-
ships of the time-course groups between spectra.
In order to perform principle component analysis
(PCA), text files within the table were imported into
MatLab® (The Mathsworksinc, Natick, MA, USA) and
data was transposed into table format. Once the time-
course group classifications had been computationallyla-
belled, the Eigenvector PLS Toolbox 7.0 was used to
perform multivariate statistical analysis on the data in
unsupervised modalities. PCA was carried out using data
normalisation and mean-centred scaling.
Direct On-tissue and lipid standard MALDI-MS Imaging
MALDI-IMS-MS images were acquired using a HDMS
Synapt™ G2 (Waters Corporation, Manchester, UK) with
an Nd:YAG laser, operated at 1 KHz. Prior to the analyses
the instrument was calibrated using phosphorus red. Data
was acquired at a range of m/z 50–1000 in the positive
mode. The acquisition of data was performed at a spatial
resolution of 50 μm × 50 μm, with the laser energy set to
185 arbitrary units. The data was then processed using the
Waters HDI software (Waters Corporation, UK). The
average spectra along with the average of ion molecule
drift time units were observed simultaneously with spatial
abundance of ions within the images. The images were
normalised against the total intensity count.
Additional MALDI-MS images were acquired using a
modified MALDI-Q-TOF, Q-Star Pulsar-i (Applied Bio-
systems/MDS Sciex, Concord Ontario, Canada) with a
NdYVO4 laser (Elforlight), operated at 5 kHz. Prior to the
analyses the instrument was calibrated using phosphorus
red. Data was acquired in positive mode at a range of m/z
50–1000. The acquisition of data was performed at a
spatial resolution of 50 μm × 50 μm using a 40 % laser en-
ergy (approximately 2.1 J). The purposes of these images
were to serve as technical repeats to the main datasets ac-
quired using the Synapt™ G2 instrument.
Histology protocols
Oil red o staining
12 μm tissue sections were cut using a cryostat (Leica
1850 UV, Leica Microsystems, Milton Keynes, UK) and
thaw mounted onto poly-lysine coated glass slides. The
mounted slides were firstly immersed into deionised
water for 2 min. The tissue slides were then immersed
into 100 ml of Oil red O (ORO) working solution (1 g
ORO in 60 % triethyl phosphate) for 20 min. After this,
the tissue slides were washed in 60 % triethyl phosphate.
Slides were mounted using glycerol gelatine mountant
medium with a cover slide; and optical images were ac-
quired using an Olympus IX81 microscope.
Haematoxylin and Eosin (H & E) Staining
Thaw mounted tissue sections were mounted onto poly-
lysine coated glass slides as described above. Sections
were fixed in 70 % and 90 % EtOH solutions, with each
wash lasting for a period of 1 min before being left to air
dry. Tissue was then immersed in filtered Harris’s
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haematoxylin for 30 s and 1 % eosin solution for 30 s.
Tissue was rinsed under running tap water after the ap-
plication of each stain. Dehydration was performed using
a series of washes in 50; 70; 80 and 95 % EtOH, each for
a period of 2 min. Finally, tissue was immersed in 4
changes of xylene for one minute each. Slides were
mounted using DPX mountant and optical images were
acquired using an Olympus IX81 microscope.
Additional file
Additional file 1: Table S1. Table of mass-spectral data produced from
profiling the full-thickness of the 24 incubated living skin equivalent tissue;
showing tentative lipid identifications (accurate measurements within
5 ppm). Figure S1: a). Drift time mobilogram for lithiated and unlithiated SM
(18:1/16:0) showing similar drift-time values for cationic variations of the lipid
compound between skin tissue and a spotted lipid standard. b) MALDI
mass spectra c). Tandem MS profiling for SM (18:1/16:0) ions in a lipid
standard and LSE tissue in the presence of lithium α-CHCA matrix;
showing corresponding product ions generated by the collision gas
target ion m/z 709. Figure S2: MALDI-MS image mapping the ion m/z
725.5 across biological replicates of skin equivalent tissue incubated for
24 h with the time-course experiment. A spot standard of sphingomyelin
(d18:1/16:0) has been included to enable putative identification of the ion
feature mapped. Images are at a spatial resolution of 50 μm × 50 μm and
normalised against the total ion count. (DOCX 2451 kb)
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